Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

May 31, 2014

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

The Estech COBRA® Surgical System

The Estech COBRA® Surgical System has been designed to create epicardial and endocardial lesions on the heart using temperature controlled radiofrequency (TCRF) ablation with the Estech COBRA surgical probes. Temperature control provides a meaningful endpoint, maintaining tissue at safe yet effective temperatures to produce the desired lesion set. Internal probe cooling and advanced suction helps to ensure reproducible transmural (full-thickness) endocardial or epicardial lesions.

Trial Locations (13)

10075

Lenox Hill Hospital / North Shore-LIJ Health System, New York

13501

Mohawk Valley Heart Institute / St. Elizabeth Medical Center, Utica

22041

Fairfax Hospital, Department of Cardiovascular and Thoracic Surgery, Falls Church

29204

Sisters of Charity, Providence Hospital, Columbia

30342

Saint Joseph's Hospital of Atlanta, Atlanta

48109

Univ. of Michigan Cardiovascular Center, Ann Arbor

53215

Aurora St. Luke's Medical Center, Milwaukee

55905

Mayo Clinic / St. Mary's Hospital, Rochester

60201

North Shore Univ. Health System, Evanston

60453

Advocate Christ Medical Center, Oak Lawn

66160

The Univ. of Kansas Hospital, Kansas City

85206

Banner Good Samaritan Medical Center, Mesa

06102

Hartford Hospital, Hartford

Sponsors
All Listed Sponsors
lead

Endoscopic Technologies, Inc

INDUSTRY